2nd Drug Delivery Conference

Fusion Conferences Ltd

20 July 2020

Dolce CampoReal Lisboa

Registration Deadline

28 May 2020

This conference focuses on the design, synthesis and clinical validation of new drug delivery vehicles. This conference is designed to bridge the gap between basic science and unmet clinical needs.

Key Sessions
1) Therapeutic gene editing

- Fundamentals of gene editing and overview of gene editing modalities (protein, gene, mRNA, viral, etc.)
- New gene editing modalities
- Approaches to delivery of therapeutic gene editing modalities – in vivo, ex vivo

2) Extrahepatic delivery of nucleic acids

3) Characterization of therapeutic nanoparticles and control strategies for manufacturing

- Molecular characterization
- Physchem characterization
- Toxicological characterization
- New methods
- Case studies from industry

4) New linkers for triggered or controlled release

5) New long acting technologies

6) Tumor targeting with nanoparticles, recent progress and challenges

Chaired by: Niren Murthy (University of California at Berkeley), Cameron Lee (Novartis) and Sanyogitta Puri (AstraZeneca)